Upload
taila-amber
View
806
Download
0
Embed Size (px)
Citation preview
HEART DISEASES IN PREGNANCY
DR. TAILA AMBER
PHYSIOLOGICAL CHANGES IN PREGNANCY
Cardiac output 30-50%
Stroke volume 30-50%
Heart rate 10-20bpm
Systemic Peripheral resistance 30%
Decrease in both systolic(3-5mmHg) &diastolicblood pressure (5-10mmHg) .
Dr. Taila Amber
Gradient between colloid oncotic pressure and
Pulmonary Capillary wedge pressure 28%
Turning from left lateral to supine position, CO
25%
PHYSIOLOGICAL CHANGES IN PREGNANCY
Dr. Taila Amber
PHYSIOLOGICAL CHANGES DURING LABOUR Rapid increase in HR and BP Increase in Cardiac Output
15% in 1st stage 50% in 2nd stage
Uterine contractions -> auto-transfusion of 300-500ml 3rd Stage: 1L blood returns to circulation Hence, risk of pulmonary edema in 2nd stage and immediately
post-partum Changes revert ---
Rapidly in 1st week Slowly in 6 weeks Some may persist for 1 year
Dr. Taila Amber
Decreased exercise capacity Tiredness Dyspnea Palpitations Light headedness
SYMPTOMS DURING NORMAL PREGNANCY THAT MAY MIMIC CARDIAC DISEASE
Dr. Taila Amber
SUSPECT HEART DISEASE
Previous history Orthopnea and PND Excessive fatigue Palpitations with sweating/syncope Chest pain
Dr. Taila Amber
SIGNS that mimic CARDIAC DISEASE
Loud S1 Exaggerated splitting of S2 Physiological S3 at the apex Systolic ejection murmur at LSB ( up to Grade 3/6) (96%) Continuous murmurs ( mammary soufflés, cervical
venous hum) Bounding pulse Ectopic beats
Dr. Taila Amber
SUSPECT HEART DISEASE Low volume pulse Tachycardia, Irregular pulse - Atrial
fibrillation Cyanosis, clubbing, Splinter
hemorrhages Signs of cardiac failure
– Raised JVP, hepatomegaly, pedal edema Pan-systolic murmurs (VSD,MR,TR)
with Thrill Late systolic murmurs (MR, MVP) Ejection systolic murmur (Grade > 3/6) Diastolic murmur Dr. Taila Amber
TYPES OF CARDIAC DISEASES
CONGENITAL ACQUIRED
PDAASD/VSDPULMONARY STENOSISTOFCONGENITAL AORTIC / MITRAL VALVE DISEASEEISENMENGER’S SYNDROMEPRIMARY PULMONARY HTNCOARCTATION OF AORTAMARFAN’S SYNDROMECONGENITAL HEART BLOCKTRICUSPID ATRESIA
RHEUMATIC HEART DISEASE MS (90%) MR (6.6%) AS (1%) AR (2.5%) TR/TSMICARDIOMYOPATHY HOCM Puerperal cardiomyopathyENDOMYOCARDIAL FIBROSISPERICARDIAL DISEASE
Dr. Taila Amber
CLASS I No functional limitation of activity. No symptoms of cardiac de-compensation with activity.
CLASS II Patients are asymptomatic at rest. Ordinary physical activity results in symptoms.
CLASS III Limitation of most physical activity. Asymptomatic at rest Minimal physical activity results in symptoms.
CLASS IV Severe limitation of physical activity results in symptoms.
Patients may be symptomatic at rest /heart failure at any point of pregnancy.
NEW YORK HEART ASSOCIATION FUNCTIONAL CLASSIFICATION OF CARDIAC DISEASE
Dr. Taila Amber
SIGNIFICANCE OF HEART DISEASEIN PREGNANCY
MATERNAL : Restricted physical
activity MM : 2.3/100,000 CAUSES:
• MS (in our country)• Cardiomyopathy• Pulmonary vascular
disease / HTN• MI• Dissecting aneurysm• Endocarditis
FETAL: Miascarriages IUGR IUD Premature delivery Increased PMR Risk of CHD = 2-4%
Cardiac disease affects 3-3.5% of all pregnancies
Dr. Taila Amber
INITIAL MANAGEMENT
• ASSESSMENT OF PREGNANT PATIENT
• FETAL ASSESSMENT
Dr. Taila Amber
ASSESSMENT OF PREGNANT PATIENTS
HISTORY
• Dyspnea : NYHA classification, onset • Fever with arthralgia• Prior events : (HF ,TIA ,STROKE). • Recurrent Cyanosis • Associated diseases : (anemia ,thyrotoxicosis ,Htn).• Drugs : (kind ,compliance ,education) • Past History• Arrhythmia • Family history
EXAMINATION
• Murmurs.• Signs of heart failure• Signs of endocarditis
ECG&ECHO
• ECG: arrhythmia.• ECHO• CXR, MRI• Angiography
Dr. Taila Amber
ECGAxis deviation to the left 15-20Small Q wavesT wave inversion in lead IIISinus tachycardia
TROPONIN Not affected by pregnancy, useful in IHD TRANSTHORACIC ECHOCARDIOGRAPHY-Cornerstone of
evaluation LV / RV / LA / RA dimensions, pericardial effusion, Small Functional TR /
PR / MR/ AR CXR MRI , CT scan ANGIOGRAPHY
INVESTIGATIONS
Dr. Taila Amber
FETAL ASSESSMENT
• 1st Trimester USG: sensitivity=85%, Specificity = 99%• 2nd Trimester (18-20wk): Optimal time• When fetal cardiac anomaly suspected:
– Full fetal Echocardiography– Detailed anomaly scan– Family history– Maternal medical history– Fetal karyotype– Referral to maternal-fetal medicine specialist ,pediatric
cardiologist, geneticist, neonatologist– Delivery where NNU facilities are available
Dr. Taila Amber
SUBSEQUENT MANAGEMENT
1. Pre-conceptional counseling, Risk stratification
2. Antepartum management
3. Peripartum management
Dr. Taila Amber
PRE-CONCEPTIONAL COUNSELLING
Obstetrician and cardiologist
Prevent an unwanted pregnancy and asses the risks associated with pregnancy
Continuation OR Termination
Dr. Taila Amber
RISK SCORE (CARPREG Study)
1. Preconception history of adverse cardiac events or arrhythmia
2. Poor functional class before pregnancy(NYHA class >II)
3. Left heart obstruction -MVA < 2 sqcm AVA <1.5sqcm Aortic valve gradient >30mmHg4. LV Ejection Fraction <40%5. Cyanosis
Estimated risk of adverse cardiac event 0 ------- 5% 1 ------- 27% >1 ------- 75%
Dr. Taila Amber
Dr. Taila Amber
Dr. Taila Amber
TERMINATION OF PREGNANCY
TERMINATION - <12wks OF PREGNANCY Eisenmenger's syndrome Marfan syndrome with aortic involvement Severe Pulmonary hypertension Coarctation of aorta Symptomatic severe AS, MS Severe left ventricular dysfunction EF<40% Metallic prosthetic valve –complications
1st and 2nd trimester : suction evacuation safe If medical management : Mifepristone in 1st
PG E1,2 , misoprostolDr. Taila Amber
ANTEPARTUM MANAGEMENT
• MEDICAL MANAGEMENT
• SURGICAL MANAGEMENT
• OBSTETRICAL MANAGEMENT
Dr. Taila Amber
MEDICAL MANAGEMENTMultidisciplinary Team – cardiologist, obstetricians,
fetal medicine specialists, pediatrician
NYHA CLASS I or II 1. Limit strenuous exercise2. Adequate rest3. Iron and Vitamins to minimize anemia 4. Low salt diet if ventricular dysfunction5. Regular cardiac and obstetric evaluation
Identify and treat early - infections, anemia, hypertension, hyperthyroidism & arrthymias
Dr. Taila Amber
NYHA CLASS III or IV
1. Hospitalisation for bed rest2. Intensive Close monitoring3. Cardiac intervention, surgery4. Termination of pregnancy
Treat precipitating events – infections, arrhythmia, anemia, hyperthyroidism
DISEASE SPECIFIC
MEDICAL MANAGEMENT
Dr. Taila Amber
SURGICAL MANAGEMENT
• Rarely required, in certain cases of acquired heart disease
• Open heart surgery avoided (10-30% Risk of fetal loss)
• Closed valvotomy or valvuloplasty preferred for valvular lesions
• Optimal time -> 2nd trimester
Dr. Taila Amber
OBSTETRICAL MANAGEMENT
Frequency of visits: 2 weeklyAssessment of cardiac status, fetal size, liquor, FM
USGAnomaly scan2 weekly growth scan
Hospital admissionLow threshold
Time and mode of delivery Labour
Dr. Taila Amber
TIME OF DELIVERY
• Multidisciplinary Approach
• TIMING OF DELIVERY:Individualized on– Cardiac status– Bishop score– Fetal well-being– Lung maturity
Dr. Taila Amber
MODE OF DELIVERY
Normal vaginal delivery - in patients hemodynamically stable (ESC guidelines)– Less risk of blood loss, infections, VTE
Cesarean section is indicated in:1. Aortic dissection2. Marfan syndrome with dilated aortic root( >45mm)3. Hemodynamically Unstabillity in particular case of
severe AS.4. Obstetric causes 5. OACs
Dr. Taila Amber
INDUCTION OF LABOUR
• BISHOP favorable : ARM & Oxytocin infusion
• BISHOP unfavorable: – Misoprostol : Low risk of coronary vasospasm &
arrhythmias– Dinoprostol: Affects B.P, Contraindicated in active
CVD– Mechanical methods preferred
Dr. Taila Amber
LABOUR Intensive Hemodynamic monitoring in severe stenotic lesions
or low EF. Admit few days before labour Pulse, BP, O2 saturation, Left lateral position. Careful attention to volume status NS < 75 ml/hour Inj. Furosemide , Digoxin - Asses pulmonary basal crepts, JVP Treatment of arrhythmias Epidural analgesia to provide analgesia and thus avoid
increase in CO due to pain and anxiety Procedures (ventouse / forceps) to cut short the 2nd stage of
labour
Dr. Taila Amber
DELIVERY IN ANTICOAGULATED WOMEN WITH PROSTHETIC VALVES
• ELECTIVE DELIVERY:– OACs shifted to LMWH / UFH from 36 weeks– LMWH shifted to UFH 36 hrs before induction/ C-section– UFH discont. 4-6 hrs before delivery, restarted 4-6 hrs after
delivery• EMERGENCY DELIVERY:
– If on UFH/LMWH --- consider Protamine– If on OACs --- C-section
• FFP & Oral Vit K (0.5-1mg) before C-section• Target INR ≤ 2• FFP & Vit K to newborn
Dr. Taila Amber
Warfarin is the favored anticoagulant during the 2nd, 3rd trimesters until the 36th wk
(Class IC ESC guidelines).
Warfarin is favored in the 1st trimester if the dose <5mg /24hrs(Class IIaC ECS guidelines)
ESC GUIDELINES
Dr. Taila Amber
POST PARTUM CARE
• Slow IV oxytocin infusion @ <2U/min• PGF analogues in PPH• Methylergometrine contraindicated (10% risk of
vasoconstriction & HTN)• Leg care, elastic stockings, early ambulation to
prevent VTE• Hemodynamic monitoring for 24-72 hours post-
partum
Dr. Taila Amber
LACTATION
• Prevents Mastitis, hence Bacteremia
• Diuretic requirement fall
• If severely unwell --- Bottle feed
Dr. Taila Amber
SPECIFIC HEART DISEASES
Dr. Taila Amber
ARRHYTHMIAS
Dr. Taila Amber
• Acute atrial flutter or atrial fibrillation treated promptly
• Ventricular Arrhythmias commonest cardiac complication during pregnancy
• If possible, all antiarrhythmic drugs should be avoided during the first trimester, and those known to be teratogenicity should be avoided throughout pregnancy.
• Because of their safety profiles, preferred drugs include digoxin, beta-blockers and adenosine.
ARRHYTHMIAS
Dr. Taila Amber
EISENMENGER’S SYNDROME• MATERNAL RISK: Mortality = 20-50%• NEONATAL OUTCOME: Live birth < 12%• MANAGEMENT:
• If Pregnancy ------ Termination• If pt. choose to continue ---
• Bed rest, O2 saturation• Anticoagulation• Diuretics if heart failure• Oral/ IV Fe, if Iron deficiency
• Delivery --- • C-section if maternal/ fetal condition
deteriorates• Otherwise, timely admission, planned deliveryDr. Taila Amber
MITRAL STENOSIS
Dr. Taila Amber
• Responsible for most of morbidity and mortality of RHD in pregnancy• MATERNAL RISK:
• Heart failure (MVA<1.5sqcm), Pulmonary edema • OBSTETRIC/ OFFSPRING RISK:
• Prematurity = 20-30%• IUGR = 5-20%• Still birth = 1-3%
• MANAGEMENT:• Moderate/Severe MS --- counsel against pregnancy• Mild MS: Echo monthly• Medical: β1 blocker, diuretics, anticoagulants• Surgical: Percutaneous mitral commisurotomy after 20 weeks in
NYHA III/IV• MOD:
• Mild --- Vaginal• Moderate/Severe ---- Cesarean section
MITRAL STENOSIS
Dr. Taila Amber
• MATERNAL RISK:– VTE in 5%– Arrhythmia
• OBSTETRIC RISK:– Pre-eclampsia– SGA
• MANAGEMENT:– MOD: Vaginal– Catheter device closure if condition deteriorates– Prevention of embolisation
• Compression stockings• Avoiding supine position• Early ambulation after delivery
ASD/VSD
Dr. Taila Amber
COARCTATION OF AORTA• MATERNAL RISK:
– Class II WHO– Risk of aortic or cerebral aneurysm rupture
• OBSTETRIC/OFFSSPRING RISK:– HTN– Miscarriage
• MANAGEMENT:– MOD: Vaginal with epidural (ESC) Cesarean section in some references – Follow up in each trimester– Treat HTN, but not to cause hypo perfusion– Percutaneous intervention could be done
Dr. Taila Amber
PERIPARTUM CARDIOMYOPATHY
Dr. Taila Amber
• Idiopathic CM presenting with heart failure secondary to LV systolic dysfunction towards end of pregnancy or in months following delivery
• EF always reduced to below 45%• PREDISPOSING FACTORS:
– Multiparity, family history, smoking, DM, HTN, Pre-eclampsia, malnutrition
• S/S: of heart failure• INVESTIGATION: Echocardiography• TREATMENT:
• Medical treatment of heart failure • Hydralazine, Nitrates, Dopamine, β blockers
are safe• ACE inhibitors, ARBs, Renin Inhibitors avoided
PERIPARTUM CARDIOMYOPATHY
Dr. Taila Amber
MYOCARDIAL INFARCTION• MATERNAL RISK:
– Rare in pregnancy– 19 % immediate mortality
• MANAGEMENT:– INITIAL:
• Opiates, anticoagulants• Coronary angiography after delivery• MOD: Vaginal with epidural analgesia• Instrumental delivery• Oxytocin infusion in 3rd stage • Ergometrine avoided
– PUERPERIUM:• MB-CPK raised• Pregnancy discouraged in futureDr. Taila Amber
Dr. Taila Amber
PREGNANCY AND DRUGS
STENOTIC LESIONS REGURGITATION LESIONS
• Bblocker: metoprolol ,propranolol (class C ),atenolol (class D ).
• C channel antagonist: verapamil , diltiazem (class C)
• Digoxin : (class C).
• Diuretic: for patient with pulmonary congestion.
• Vasodilators: only If BP is high :• Hydralazine:(class C ).• Nitrate :(class C ).
• Diuretic:• Thiazide: ( class B).• Loop diuretic: (class C ).• Avoid hypotension & placental
hypoperfusion
ACE inhibitor ,ARBS (class X ).
Dr. Taila Amber
CONTRACEPTION
• Barrier methods – unreliable.• COC contraindicated.• Progesterone only pill have better side effect profile
& long acting slow releasing as Mirena intrauterine system have improved efficacy.
• Sterilization where family completed. (Laparoscopic clip sterilization carries risk).
Dr. Taila Amber
CONCLUSIONPregnancy causes significant haemodynamic changes
and imposes an additional burden on the cardiac patient, especially around the time of labour and in the immediate puerperium.
To achieve a successful pregnancy outcome, a clear understanding of these haemodynamic adaptations as well as meticulous maternal and foetal surveillance for risk factors and complications throughout the pregnancy is essential.
Dr. Taila Amber
CONCLUSION
Appropriate contraceptive and family planning advice as well as pre-conceptional counseling are also important.
The concerted efforts of a team consisting of theobstetrician, cardiologist, anesthetist, cardiothoracic surgeon, neonatologist, and pediatric cardiologist are mandatory to ensure optimal results.
Dr. Taila Amber
THANK YOU
Dr. Taila Amber